This report provides key findings from the 2022 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment among the noninstitutionalized U.S. population aged 12 or older. Estimates are presented by age group and by race/ethnicity for selected measures.
Dashboard: Filter Bricks
Main page content
![Results from the 2022 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States](/sites/default/files/styles/product_thumbnail_dashboard/public/pep23-07-01-006.png?itok=39BNch5o)
![Results from the 2021 National Survey on Drug Use and Health (NSDUH): Key Substance Use and Mental Health Indicators in the United States](/sites/default/files/styles/product_thumbnail_dashboard/public/pep22-07-01-005.png?itok=mpe24rrC)
Read key findings from the 2021 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Estimates are presented by age group and by race/ethnicity for selected measures. Unlike other NSDUH Annual National Reports, the 2021 report has no discussion of trends over time, because changes in survey methodology mean the indicators are not comparable to past NSDUH estimates.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-06-01-002.png?itok=gWWwdKdj)
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
![](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-06-02-001.png?itok=7DZ2RwhJ)
This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
![Racial/Ethnic Differences in Mental Health Service Use among Adults and Adolescents](/sites/default/files/styles/product_thumbnail_dashboard/public/pep21-07-01-002.png?itok=ReEYDekV)
This chartbook uses combined 2015 to 2019 data from the National Survey on Drug Use and Health (NSDUH) to present nationally representative estimates of mental health service utilization among adults aged 18 or older and adolescents aged 12 to 17 within different racial/ethnic groups in the United States. The percentages are annual averages.
![Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets](/sites/default/files/styles/product_thumbnail_dashboard/public/pep20-03-02-001.png?itok=WqnHUycy)
The EAP Prescription Drug Toolkit and Fact Sheets provide guidance related to counseling, referrals, and follow-up services (e.g., alternatives to prescription drugs, workplace drug misuse and relapse prevention, dangers of combined drug use, screenings, and evaluations before returning to work).
![Advisory: Using Motivational Interviewing in Substance Use Disorder Treatment (based on TIP 35)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-02-014.jpg?itok=9Jlhmlx6)
This Advisory is based on TIP 35, Enhancing Motivation for Change in Substance Use Disorder Treatment. It addresses the spirit, application, and fundamentals of motivational interviewing (MI), discusses how practitioners can effectively employ MI in substance use disorder (SUD) treatment, and provides tools that practitioners can use to encourage and promote lasting positive outcomes for their clients.
![Advisory: Screening and Treatment of Substance Use Disorders among Adolescents (based on TIP 31-32)](/sites/default/files/styles/product_thumbnail_dashboard/public/pep20-06-04-008.png?itok=oauf3cDu)
This Advisory is based on TIP 31, Screening and Assessing Adolescents for Substance Use Disorders (SUDs) and TIP 32, Treatment of Adolescents with SUDs. It includes recommendations for engaging adolescents in SUD risk assessment, screening, and treatment.
![Advisory: The Substance Use Disorder Counseling Competency Framework: An Overview (based on TAP 21)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-01-017.jpg?itok=mJLA9zqI)
This Advisory is based on Technical Assistance Publication (TAP) 21, Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice. It discusses the development of the counseling competencies and the validated research on which they are based, provides a simplified overview of their structure and the elements of a typical competency, and outlines how these competencies are changing the field of substance use disorder (SUD) treatment nationwide. The Advisory also addresses the critical role of cultural competency.
![Advisory: Prescribing Pharmacotherapies for Patients With Alcohol Use Disorder (based on TIP 49)](/sites/default/files/styles/product_thumbnail_dashboard/public/PEP20-02-02-015.jpg?itok=k-lPfGkF)
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
Displaying 1 - 10 out of 83